Literature DB >> 13710014

A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog.

A B GUTMAN, P G DAYTON, T F YU, L BERGER, W CHEN, L E SICAM, J J BURNS.   

Abstract

Entities:  

Keywords:  KIDNEY/physiology; PHENYLBUTAZONE/related compounds

Mesh:

Substances:

Year:  1960        PMID: 13710014     DOI: 10.1016/0002-9343(60)90082-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

1.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

2.  Renal tubular secretion and reabsorption of organic bases in the dog.

Authors:  J TORRETTI; I M WEINER; G H MUDGE
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  The influence of urine pH on the renal excretion of ICI 66082 in man.

Authors:  C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

4.  The influence of urinary pH on the elimination of mexiletine.

Authors:  M A Kiddie; C M Kaye; P Turner; T R Shaw
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

Review 5.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

6.  Proximal tubular reabsorption of some organic acids in the rat kidney in vivo.

Authors:  H Sonnenberg; H Oelert; K Baumann
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1965-10-12

Review 7.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

8.  Pyrazinoate excretion in the chimpanzee. Relation to urate disposition and the actions of uricosuric drugs.

Authors:  G M Fanelli; I M Weiner
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1977-01-15

10.  Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man.

Authors:  W Dieterle; J W Faigle; H Mory; W J Richter; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.